Crosspoint Capital Strategies Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$3.66M |
| 2 |
SolarEdge
SEDG
|
+$3.63M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$3.57M |
| 4 |
CTRL
Control4 Corporation
CTRL
|
+$3.57M |
| 5 |
OraSure Technologies
OSUR
|
+$3.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$5.83M |
| 2 |
Chegg
CHGG
|
+$4.05M |
| 3 |
Supernus Pharmaceuticals
SUPN
|
+$3.85M |
| 4 |
Wayfair
W
|
+$3.84M |
| 5 |
MiMedx Group
MDXG
|
+$3.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.65% |
| 2 | Consumer Discretionary | 20.05% |
| 3 | Healthcare | 19.63% |
| 4 | Consumer Staples | 9.11% |
| 5 | Industrials | 6.67% |
Similar funds
Crosspoint Capital Strategies's Q3 2017 Portfolio in Review
As of Q3 2017, Crosspoint Capital Strategies held 194 positions worth $129M, up 13% from $114M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Crosspoint Capital Strategies withdrew a net $7.03M in Q3 2017, closing 72 positions and reducing 22 holdings. Its most notable exit was Clovis Oncology, Inc., an estimated $5.83M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Crosspoint Capital Strategies opened a new position in Boeing worth $3.99M.
- Crosspoint Capital Strategies's largest Q3 2017 buy was Boeing: 15,706 shares worth $3.99M.
- Crosspoint Capital Strategies added most to Control4 Corporation in Q3 2017, an estimated $3.57M increase.
- Crosspoint Capital Strategies's biggest Q3 2017 reduction was Chegg, cutting an estimated $4.05M.
- Crosspoint Capital Strategies fully exited Clovis Oncology, Inc. in Q3 2017, selling an estimated $5.83M.
- Crosspoint Capital Strategies's ten largest holdings make up 32% of its $129M portfolio in Q3 2017.
- Crosspoint Capital Strategies opened 55 new positions and closed 72 in Q3 2017.
- Crosspoint Capital Strategies's portfolio value rose 13% quarter-over-quarter to $129M.
Based on Crosspoint Capital Strategies's 13F filing for Q3 2017, filed 6 Nov 2017.